Modulators of the sigma-2 receptor and their method of use
Grant
US12577251B2
Kind: B2
Mar 17, 2026
Assignee
Temple University—Of The Commonwealth System of Higher Education
Inventors
Benjamin E. Blass, Daniel J. Canney, Kevin M. Blattner
Abstract
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of sigma-2 receptor activity.
CPC Classifications
C07D 487/04
Filing Date
2023-10-11
Application No.
18484858
Claims
6